Emergent BioSolutions
EBS
#6766
Rank
A$0.95 B
Marketcap
A$17.92
Share price
-1.24%
Change (1 day)
26.29%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): A$0.25 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.75 Billion. In 2024 the company made an earning of -A$0.11 Billion, an increase over its 2023 earnings that were of -A$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.25 B-338.73%
2024 -A$0.11 Billion-88.82%
2023 -A$0.97 Billion242.73%
2022 -A$0.29 Billion-153.8%
2021 A$0.52 B-20.43%
2020 A$0.66 B278.02%
2019 A$0.17 B27.11%
2018 A$0.13 B-27.12%
2017 A$0.18 B17.21%
2016 A$0.16 B0.45%
2015 A$0.16 B73.51%
2014 A$92.29 M41.36%
2013 A$65.28 M35.2%
2012 A$48.29 M0.4%
2011 A$48.09 M-56.46%
2010 A$0.11 B76.73%
2009 A$62.5 M32.94%
2008 A$47.01 M-5.62%
2007 A$49.82 M
2005 A$72.13 M269.89%
2004 A$19.5 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$34.76 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.13 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.03 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.39 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.66 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-A$18.63 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA